Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The 10 Most-Frequently Read Articles
in Ann Rheum Dis during July 2008 -- updated monthly

These articles have received the most "hits" in Annals of the Rheumatic Diseases during July 2008.

VIEW LIST BY SECTION:
 
-> Overall Report
1.  C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, J W Cohen-Tervaert, W L Gross, L Guillevin, D Jayne, A Mahr, P A Merkel, H Raspe, D Scott, J Witter, H Yazici, R A Luqmani, on behalf of the European Vasculitis Study Group (EUVAS)
  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
  Ann. Rheum. Dis. 2008; 67: 1004-1010.
(In "Extended reports")   [Abstract]     [Full Text]     [PDF]
 
2.  G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, D Isenberg, C G M Kallenberg, M Khamashta, J C Piette, M Schneider, J Smolen, G Sturfelt, A Tincani, R van Vollenhoven, C Gordon, D T Boumpas
  EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
  Ann. Rheum. Dis. 2008; 67: 195-205.
(In "Extended reports")   [Abstract]     [Full Text]     [PDF]
 
3.  Xavier Bossuyt, Céline Louche, Allan Wiik
  Standardisation in clinical laboratory medicine: an ethical reflection
 Current issue Ann. Rheum. Dis. 2008; 67: 1061-1063.
(In "Editorials")   [Full Text]     [PDF]
 
4.  M Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, S Nayiager, C Saldate, T Li, R Aranda, J-C Becker, C Lin, P L N Cornet, M Dougados
  Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
 Current issue Ann. Rheum. Dis. 2008; 67: 1096-1103.
(In "Extended reports")   [Abstract]     [Full Text]     [PDF]
 
5.  H K Genant, C G Peterfy, R Westhovens, J-C Becker, R Aranda, G Vratsanos, J Teng, J M Kremer
  Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
 Current issue Ann. Rheum. Dis. 2008; 67: 1084-1089.
(In "Extended reports")   [Abstract]     [Full Text]     [PDF]
 
   [Next 5 Articles]

Current issue = from the current issue

Last Updated: 08/02/2008 21:08:47


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism